Nigella Sativa flowering plant (sewn) growing in North Africa and Western Asia can be used in the future as a new tool against COVID-19. This is reported in the article published in the magazine Clinical and Experimental Pharmacology and Physiology. Briefly about the study describes the press release on MedicalXpress.
Specialists found that Timohyinone, the active ingredient N.Sativa, can bind to the SARS-COV-2 coronavirus S-protever and not give the virus to cause a pulmonary infection. According to scientists, it can also block a cytokine storm, which manifests itself in serious patients hospitalized with COVID-19.
has already been proven that Timohyinone prevents the release of pro-inflammatory chemicals, such as interleukins. Thus, it can play a potential role in the treatment of allergic conditions, such as asthma or eczema, as well as arthritis, including rheumatoid and osteoarthritis, and even sclerosis.
Chernushka sowing is also useful in the treatment of high blood pressure, high cholesterol and diabetes mellitus. As an anti-inflammatory medium N.Sativa helps patients with allergic rhinitis and sinusitis, as well as children’s epilepsy.